Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 Study of Vorinostat in Combination With Radiation Therapy and Infusional 5-FU in Patients With Locally Advanced Adenocarcinoma of the Pancreas

NCT00948688 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00948688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00948688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 Study of Vorinostat in Combination With Radiation Therapy and Infusional 5-FU in Patients With Locally Advanced Adenocarcinoma of the Pancreas
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1/2
Overall status
Terminated
Start date
August 31, 2009
Completion date
November 30, 2013
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the pancreas, pancreatic cancer